FluoroPharma Medical, Inc.
| OTC Markets: FPMI
FluoroPharma Medical, Inc. is a biopharmaceutical company, which specializes in discovering, developing and commercializing molecular imaging pharmaceuticals with initial applications in the area of cardiology. It has two clinical-stage molecular imaging pharmaceutical product candidates: CardioPET and BFPET. The company was founded on January 25, 2007 and is headquartered in Montclair, NJ.